• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

GALAPAGOS (GLPG)

GALAPAGOS
Sell: €24.20|Buy: €25.00|Change: 0.06 (-0.24%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Address

Generaal De Wittelaan L11 A3
Mechelen
BEL
2800

Telephone

+1 781 4601784

Website

https://www.glpg.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Galapagos NV Annual General Meeting for 20272027-04-28T14:00:00
Galapagos NV Annual Report for 20262027-03-26T00:00:00
Galapagos NV Fourth Quarter Earnings Conference Call for 20262027-02-24T08:00:00
Galapagos NV Fourth Quarter Earnings Results for 20262027-02-24T00:00:00
Galapagos NV Third Quarter Earnings Conference Call for 20262026-11-13T00:00:00
Galapagos NV Third Quarter Earnings Results for 20262026-11-12T00:00:00
Galapagos NV Second Quarter Earnings Conference Call for 20262026-08-11T00:00:00
Galapagos NV Second Quarter Earnings Results for 20262026-08-10T00:00:00
Galapagos NV First Quarter Earnings Conference Call for 20262026-05-07T00:00:00
Galapagos NV First Quarter Earnings Results for 20262026-05-06T00:00:00
Galapagos NV Annual General Meeting for 20262026-04-28T14:00:00

Previous key dates

NameKey Date
Galapagos NV Annual General Meeting for 20262026-04-28T14:00:00
Galapagos NV Annual Report for 20252026-03-26T00:00:00
Galapagos NV Fourth Quarter Earnings Conference Call for 20252026-02-24T08:00:00
Galapagos NV Fourth Quarter Earnings Result for 20252026-02-24T00:00:00
Galapagos NV Third Quarter Earnings Conference Call for 20252025-11-06T18:30:00
Galapagos NV Third Quarter Earnings Results for 20252025-11-05T00:00:00
Galapagos NV Second Quarter Earnings Conference Call for 20252025-07-24T00:00:00
Galapagos NV Second Quarter Earnings Results for 20252025-07-23T00:00:00
Galapagos NV Annual General Meeting for 20252025-04-29T00:00:00
Galapagos NV First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
Galapagos NV First Quarter Earnings Results for 20252025-04-23T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.